<DOC>
	<DOCNO>NCT00600093</DOCNO>
	<brief_summary>The purpose study determine whether administrate Amantadine ( dopamine agonist ) patient suffer Parkinson disease perioperative period safe , asses potential benefit treatment .</brief_summary>
	<brief_title>Perioperative Treatment Parkinsonian Patients With Parenteral Amantadine</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Amantadine</mesh_term>
	<criteria>Patient diagnosis Parkinson Disease refer surgery institution . Cardiac neurosurgical procedure Inability sign inform Consent allergy Amantadine Congestive heart failure Arrythmia ( include bradycardia 55 bpm ) renal failure ( creatinin 1.5 ) If patient develop agitation delirium lasting longer 8 hour receive second dose amantadine .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Amantadine</keyword>
</DOC>